该重组B4GALT1产物可用于研究该酶的作用方式及其潜在的抑制剂。它还可用作体外修饰糖蛋白的糖工程工具。应用： 重组人β-1,4-半乳糖基转移酶1（B4GALT1）在人HEK 293细胞中表达为糖蛋白，计算分子量为40 kDa。由于糖基化作用，DTT还原蛋白在SDS-PAGE上以~55 kDa多肽形式迁移。这种蛋白质是在人细胞中产生的，不含血清。人细胞表达系统允许类人糖基化和折叠，通常支持比活性更高的蛋白质。 Recombinant human Beta-1,4-galactosyltransferase 1 (B4GALT1) is expressed in human HEK 293 cells as a glycoprotein with a calculated molecular mass of 40 kDa. The DTT-reduced protein migrates as a ~55 kDa polypeptide on SDS-PAGE due to glycosylation. This protein is manufactured in human cells, with no serum. The human cells expression system allows human-like glycosylation and folding, and often supports higher specific activity of the protein. Application: This recombinant B4GALT1 product can be used to study the mode of action of the enzyme, as well as its potential inhibitors. It can also be used as a glycoengineering tool to modify glycoproteins in vitro.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
β-1,4-半乳糖基转移酶1
CAS number：unknown molecular formula：
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | |
| molecular weight | - | Exact mass | 重组 |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
